Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-031188

Chief Commercial Officer sold 9,394 shares at $25.28 ($237,480)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Oliver Tracie · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-07-02 Sale : show line 1 in the form 10b5-1 −9,394 $25.28 $237,480 127,107 D
Open-market sales · 9,394 sh · avg $25.28 · $237,480
Loading xslF345X05/wk-form4_1720042050.xml…